In line with these findings, reduced ISG15 levels were observed in drug-resistant cancer cell lines and ISG15 overexpressing breast tumor cells were shown to have heightened sensitivity to the anticancer drug camptothecin (Topotecan) (104). Here, ISG15 is linked to breast neoplasm.